Kevin Guest

Kevin Guest, listed as chief executive, appears in our data through filings on Usana Health Sciences Inc shares, published by SEC (Form 4). We count 54 filings; the first trade dates from 15 August 2016 and the latest from 27 February 2026.

On the market, this insider has only sold: 14 sales, €8.6M in total. The rest of the record consists of 10 share grants and 30 option exercises.

The newest entry dates from 3 March 2026: an option exercise, in Usana Health Sciences Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.